Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

BlackRock, Inc. reported a 5.20% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 30, 2026

BlackRock, Inc. reported a 5.20% stake in Zentalis Pharmaceuticals, Inc., 3,710,914 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).

Stake
5.20%
Shares
3,710,914
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.20%3,710,914

Source

View original at SEC

Related